CINV

Crucial Innovations Corp. Launches 4TP, a New Patient-Focused Brand of Cannabis-Based Products for Medicinal Use

LONDON, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Crucial Innovations Corp. (OTC: CINV), a pharmaceutical biotechnology platform advancing consistent and ethically produced Cannabis-Based Products for Medicinal Use (CBPMs) across the UK and Europe, announced the launch of 4TP, a new patient-facing brand developed in collaboration with CINV's GMP-licensed cultivation and processing partners. The launch of 4TP reflects CINV's Plant-to-Patient operating model, a fully governed medical supply and delivery framework that spans regulated cultivation, pharmaceutical-grade processing, regulatory quality systems and clinician-led patient access.